Inventor · disambiguated record
Anton Belousov
Also filed as: BELOUSOV ANTON · BELOUSOV ANTON BORISOVICH
4 granted patents·8 pending applications·129 citations·filing 1996–2025
73Inventor score
Top patents by PatentIndex Score
12 records- 0184US6328342B1Tape data carrier, method and device for manufacturing the sameFiled 1996·Granted Dec 11, 2001·119 cites·66 claims
- 0281US9047438B2Chromatography equipment characterizationHOFFMANN LA ROCHE·Filed 2013·Granted Jun 2, 2015·8 cites·14 claims
- 0379US2022282337A1Identification of patients in need of pd-l1 inhibitor cotherapyHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 0478US2025340948A1Identification of patients in need of pd-l1 inhibitor cotherapyHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 0578US2022170115A1Identification of patients in need of pd-l1 inhibitor cotherapyHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 0676US2022090212A1Identification of patients in need of pd-l1 inhibitor cotherapyHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 0770US2020199690A1Identification of patients in need of pd-l1 inhibitor cotherapyHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 0866US2018274038A1Identification of patients in need of pd-l-1 inhibitor cotherapyHOFFMANN LA ROCHE·Filed 2017·Application pending·0 cites
- 0965US8357301B2Chromatography equipment characterizationHOFFMANN LA ROCHE·Filed 2010·Granted Jan 22, 2013·2 cites·18 claims
- 1061US2016333414A1Identification of patients in need of pd-l1 inhibitor cotherapyHOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
- 1153US2023197278A1Multi-variate model for predicting cytokine release syndromeGENENTECH INC·Filed 2022·Application pending·0 cites
- 1232US11760807B2GPC3-targeting drug which is administered to patient responsive to GPC3-targeting drug therapyCHUGAI PHARMACEUTICAL CO LTD·Filed 2015·Granted Sep 19, 2023·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Anton Belousov files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →